Schwartz Aharon bought PLX
June 10, 2025 · Form 4 insider transaction
Schwartz Aharon bought 129,000 shares of Protalix BioTherapeutics, Inc. at $1.60 per share, a transaction worth $205.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 63 days after the transaction.
Direction
Acquired (buy-side)
Shares
129,000
Price
$1.60
Total value
$205.9K
InsiderSchwartz Aharon
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 10, 2025
Filing dateAugust 12, 2025
Shares owned after303,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was executed in multiple trades at prices ranging from $1.60 to $1.575 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.